10 results
The aim of this study is to evaluate the safety and feasibility of postoperative pericardial perfusion with (prewarmed NaCl 0.9%) and the effect of perfusion on blood loss after cardiac surgery. Hypothesis Pericardial perfusion with (prewarmed NaCl…
Objectives of the randomized controlled trialPrimary objective: To determine whether postoperative pericardial flush with a crystalloid can reduce postoperative blood loss by effectively removing contaminated pericardial blood after CABG. The…
1: determine the additional predictive value of MRI measures of brain connectivity on top of existing clinical parameters for cognitive recovery or deterioration in the first year after stroke.2: assess feasibility of a standardized work*up…
The primary objective is to determine the penetration of cefazolin and clindamycin in synovial fluid and bone tissue related to the serum concentration in subjects undergoing reimplantation of the hip.
Primary objective: To determine whether postoperative pericardial flush with a crystalloid can reduce postoperative blood loss by effectively removing contaminated pericardial blood after valvular surgery and correction for CHD. The primary…
The primary objective is to evaluate the feasibility of early therapeutic effect evaluation by performing early follow up imaging after percutaneous MR-guided cryoablation of pT1a renal cell carcinoma. Secondary objective is to assess the outcomes…
The purpose of the study is to test whether a centre-wide policy of incremental antibiotic therapy will reduce arrhythmia device infection in patients undergoing arrhythmia device procedures compared to a policy of conventional antibiotic…
The primary objective is to determine the absorption of orally administered antibiotics in patients with SBS, to guide in clinical decision making when faced with catheter related infections.
Identification of MRI-based biomarkers to predict clinical outcome of major depressive disorder in comparison with healthy controls. Outcome is defined by level of depressive and cognitive symptomatology and related comorbidity.
To determine whether 4 weeks of total antibiotic treatment duration is non-inferior to 6 weeks in patients with complicated SAB who have responded well to the initial treatment.